24 HR ropinirole 4 MG Extended Release Oral Tablet

1 INDICATIONS AND USAGE Ropinirole extended-release tablets are indicated for the treatment of Parkinson’s disease. Ropinirole extended-release tablets are a non-ergoline dopamine agonist indicated for the treatment of Parkinson’s disease. ( 1 )

Actavis Pharma, Inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] toxicity to various agents` `[3] off label use` `[4] completed suicide` `[5] drug abuse` `[6] nausea` `[7] death` `[8] vomiting` `[9] pyrexia` `[10] overdose`

4 years ago

OVAL BLUE 659

16 HOW SUPPLIED/STORAGE AND HANDLING Each oval-shaped tablet contains

ROPINIROLE hydrochloride, USP equivalent to the labeled amount of

ROPINIROLE as follows: 2 mg, pink, oval-shaped, unscored, film-coated tablets, debossed with and 658 on one side and plain on the other side, in bottles of 30 (NDC 0228-3658-03) and 90 (NDC 0228-3658-09). 4 mg, blue, oval-shaped, unscored, film-coated tablets, debossed with and 659 on one side and plain on the other side, in bottles of 30 (NDC 0228-3659-03) and 90 (NDC 0228-3659-09). 6 mg, white to off-white, oval-shaped, unscored, film-coated tablets, debossed with and 640 on one side and plain on the other side, in bottles of 30 (NDC 0228-3640-03). 8 mg, red, oval-shaped, unscored, film-coated tablets, debossed with and 660 on one side and plain on the other side, in bottles of 30 (NDC 0228-3660-03) and 90 (NDC 0228-3660-09). 12 mg, yellow, oval-shaped, unscored, film-coated tablets, debossed with and 661 on one side and plain on the other side, in bottles of 30 (NDC 0228-3661-03). Storage Store at 25ºC (77ºF); excursions permitted to 15º to 30ºC (59º to 86ºF) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP. 54887e95-figure-07 54887e95-figure-08 54887e95-figure-09 54887e95-figure-10 54887e95-figure-11

More pills like OVAL 659

Related Pills

day time multisymptom flu cold medicine acetaminophen dextromethorphan hbr phenylephrine hcl capsule liquid filled

salado sales, inc.

Clonidine Hydrochloride 0.3 MG Oral Tablet

Mutual Pharmaceutical Company, Inc.

Pyridostigmine Bromide 60 MG Oral Tablet

Zydus Pharmaceuticals (USA) Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site